Feasibility of HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for advanced pediatric malignancies.

MLA

Sawada, Akihisa, et al. “Feasibility of HLA-Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Advanced Pediatric Malignancies.” Pediatric Hematology and Oncology, vol. 31, no. 8, Nov. 2014, pp. 754–64. EBSCOhost, https://doi.org/10.3109/08880018.2014.961214.

APA

Sawada, A., Shimizu, M., Isaka, K., Higuchi, K., Mayumi, A., Yoshimoto, Y., Kikuchi, H., Kondo, O., Koyama-Sato, M., Yasui, M., Kawa, K., & Inoue, M. (2014). Feasibility of HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for advanced pediatric malignancies. Pediatric Hematology and Oncology, 31(8), 754–764. https://doi.org/10.3109/08880018.2014.961214

Chicago

Sawada, Akihisa, Mariko Shimizu, Kanako Isaka, Kouhei Higuchi, Azusa Mayumi, Yuri Yoshimoto, Hiroaki Kikuchi, et al. 2014. “Feasibility of HLA-Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Advanced Pediatric Malignancies.” Pediatric Hematology and Oncology 31 (8): 754–64. doi:10.3109/08880018.2014.961214.